Medical device maker Abbott has received emergency authorization from the U.S. Food and Drug Administration (FDA) for its new molecular poi...
Medical device maker Abbott has received emergency authorization from the U.S. Food and Drug Administration (FDA) for its new molecular point-of-care covid-19 test, which will allow healthcare providers in a variety of different settings to obtain results almost immediately. The new test can deliver positive results…
from Gizmodo https://ift.tt/3aqXMTx
via IFTTT
COMMENTS